We are live on ! Find out more
PODD icon

Insulet

682 hedge funds and large institutions have $18.4B invested in Insulet in 2024 Q4 according to their latest regulatory filings, with 126 funds opening new positions, 248 increasing their positions, 225 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

133% more first-time investments, than exits

New positions opened: 126 | Existing positions closed: 54

12% more capital invested

Capital invested by funds: $16.5B → $18.4B (+$1.93B)

10% more repeat investments, than reductions

Existing positions increased: 248 | Existing positions reduced: 225

10% more funds holding

Funds holding: 622682 (+60)

0.56% less ownership

Funds ownership: 101.1%100.53% (-0.56%)

31% less call options, than puts

Call options by funds: $123M | Put options by funds: $177M

Holders
682
Holders Change
+60
Holders Change %
+9.65%
% of All Funds
8.98%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.07%
New
126
Increased
248
Reduced
225
Closed
54
Calls
$123M
Puts
$177M
Net Calls
-$54.3M
Net Calls Change
+$11.6M

PODD Hedge Fund Activity: Q4 2024 in Review

682 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q4 2024, worth a combined $18.4B — up 12% from $16.5B a quarter earlier.

Buyers outnumbered sellers: 126 funds opened new PODD positions and 54 closed out — a net gain of 72 holders — while 248 added to existing stakes and 225 trimmed.

The largest buyer was BlackRock, adding an estimated $70.3M. The largest seller was Goldman Sachs, cutting an estimated $83M.

  • 682 institutional investors held Insulet (PODD) as of Q4 2024, up from 622 in Q3 2024.
  • Funds reported $18.4B of Insulet stock for Q4 2024, up 12% quarter-over-quarter.
  • 126 funds opened new Insulet positions in Q4 2024 and 54 closed out, a net change of +72 holders.
  • The largest Insulet buyer in Q4 2024 was BlackRock, an estimated $70.3M added.
  • The largest Insulet seller in Q4 2024 was Goldman Sachs, an estimated $83M sold.

Based on aggregated 13F filings for Q4 2024.